Rafael Alonso Fernández (Rafael Alonso, Rafael Alonso Fernandez)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Multiple Myeloma

Ejection Fraction

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente, Maria Luz Morales, Rubén Gómez-Gordo, Pablo Justo, Clara Cuéllar, José María Sánchez-Pina, Nieves López-Muñoz, Rafael Alonso Fernández, Noemi Puig, Maria-Victoria Mateos-Manteca, Rosa María Ayala, Maria Dulcenombre Gómez-Garré, Joaquin Martinez Lopez, María Linares
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente, Maria Luz Morales, Rubén Gómez-Gordo, Pablo Justo, Clara Cuéllar, José María Sánchez-Pina, Nieves López-Muñoz, Rafael Alonso Fernández, Noemi Puig, Maria-Victoria Mateos-Manteca, Rosa María Ayala, Maria Dulcenombre Gómez-Garré, Joaquin Martinez Lopez, María Linares
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente, Maria Luz Morales, Rubén Gómez-Gordo, Pablo Justo, Clara Cuéllar, José María Sánchez-Pina, Nieves López-Muñoz, Rafael Alonso Fernández, Noemi Puig, Maria-Victoria Mateos-Manteca, Rosa María Ayala, Maria Dulcenombre Gómez-Garré, Joaquin Martinez Lopez, María Linares
Short-chain fatty acid production by gut microbiota predicts treatment response in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Eva Milara, Rafael Alonso Fernández, Lena Masseing, Alexander P Seiffert, Adolfo Gómez Grande, Enrique J Gómez, Joaquin Martinez Lopez, Patricia Sánchez-González
Radiomics analysis of bone marrow biopsy locations in [ 18 F]FDG PET/CT images for measurable residual disease assessment in multiple myeloma. Physical and engineering sciences in medicine (2023)
Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Rafael Alonso Fernández, Jessica Encinas, Laetitia Pierre-Louis, Yao Yao, Yan Xu, Shidai Mu, Joaquin Martínez-López, Daniel Primo, Takahiro Miyazaki, Rao H Prabhala, Kenneth C Anderson, Willem W Overwijk, Nikhil C Munshi, Mariateresa Fulciniti
Improving NK Cell Function in Multiple Myeloma with NKTR-255, a Novel Polymer-Conjugated Human IL-15. Blood advances (2022)
Larissa Haertle, Santiago Barrio, Umair Munawar, Seungbin Han, Xiang Zhou, Michal Simicek, Cornelia Vogt, Marietta Truger, Rafael Alonso Fernández, Maximilian Johannes Steinhardt, Julia Weingart, Renata Snaurova, Silvia Nerreter, Eva Teufel, Andoni Garitano-Trojaola, Matteo Claudio Da Via, Yanira Ruiz-Heredia, Andreas Rosenwald, Niccolo' Bolli, Roman Hájek, Peter Raab, Marc-Steffen Raab, Niels Weinhold, Claudia Haferlach, Thomas Haaf, Joaquin Martinez Lopez, Hermann Einsele, Leo Rasche, Klaus Martin Kortüm
Single Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Rafael Alonso Fernández, María-Teresa Cedena, Adolfo Gómez-Grande, Rafael Ríos, José María Moraleda, Valentín Cabañas, María José Moreno, Javier López-Jiménez, Fernando Martín, Alejandro Sanz, Antonio Valeri, Ana Jiménez, Ricardo Sanchez, Juan José Lahuerta, Joaquin Martinez-Lopez
Imaging and bone marrow assessments improve minimal residual disease prediction in multiple myeloma. American journal of hematology 94 (8) (2019)